Box score
GT Biopharma, Inc.
Reported $7.8M sold in a new Form D filed September 29, 2026 (San Francisco, California).
- Biggest raise
- $7.8M filed Sep 29, 2026
- League
- Bio & Health Biotechnology
- Based in
- San Francisco, California
- Season rank
- #248 of 1,121 in the Bio & Health League; #2155 of 10,745 overall (2026)
- Entity
- Corporation
Form D filings since 2024 4
| Filed | Form | Sold | Offering | Filing |
|---|---|---|---|---|
| 2026-09-29 | New notice | $7.8M | $39M | SEC |
| 2025-05-28 | New notice not ranked | $0 | $20M | SEC |
| 2025-05-27 | New notice | $6M | $6M | SEC |
| 2025-03-07 | New notice | $1.3M | $1.3M | SEC |
Amounts are cumulative for each offering as of the filing date, so an amendment can repeat or update an earlier figure; filings are not added together. CIK 109657.
Similar raises, 2026
| # | Company | League | Raised |
|---|---|---|---|
| 1 | ALZpath, Inc. rookie | Bio & Health | $8.4M |
| 2 | Tempest Therapeutics, Inc. | Bio & Health | $7.5M |
| 3 | Avenue Biosciences Holding Inc rookie | Bio & Health | $7.4M |
| 4 | XDemics Corp | Bio & Health | $7.4M |
| 5 | Allswell Health PBC rookie provisional | Bio & Health | $6.8M |
| 6 | Shape Memory Medical Inc. | Bio & Health | $6.7M |